IGIV3I Grifols 10% ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
63特発性血小板減少性紫斑病1

63. 特発性血小板減少性紫斑病


臨床試験数 : 391 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00511147
(ClinicalTrials.gov)
May 20081/8/2007IGIV Study for Chronic ITP Patients Ages 3-70A Multi-center, Prospective, Open-label, Clinical Trial to Assess the Safety and the Efficacy of a New Intravenous Immune Globulin (IGIV3I Grifols 10%) in Patients With Idiopathic (Immune) Thrombocytopenic PurpuraIdiopathic Thrombocytopenic PurpuraBiological: IGIV3I Grifols 10%Grifols Biologicals Inc.Instituto Grifols, S.A.Completed3 Years70 YearsAll64Phase 3United States;Canada;India;Puerto Rico